These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8267510)

  • 1. [Non-pharmacological treatment of ventricular tachycardia (anti-arrhythmic surgery excluded)].
    Touboul P
    Arch Mal Coeur Vaiss; 1993 May; 86(5 Suppl):809-17. PubMed ID: 8267510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study.
    Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E;
    Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiofrequency ablation in ventricular tachycardia: an alternative to implanted cardioverter defibrillator?].
    Noble S; Shah D
    Rev Med Suisse; 2006 May; 2(67):1406, 1408-11. PubMed ID: 16786957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-Guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators.
    Dickfeld T; Tian J; Ahmad G; Jimenez A; Turgeman A; Kuk R; Peters M; Saliaris A; Saba M; Shorofsky S; Jeudy J
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):172-84. PubMed ID: 21270103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.
    Carbucicchio C; Santamaria M; Trevisi N; Maccabelli G; Giraldi F; Fassini G; Riva S; Moltrasio M; Cireddu M; Veglia F; Della Bella P
    Circulation; 2008 Jan; 117(4):462-9. PubMed ID: 18172038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of defibrillation shocks for resuscitation of rapid ventricular tachycardia: does it make a difference?
    Turner I; Turner S; Grace AA
    Resuscitation; 2009 Feb; 80(2):183-8. PubMed ID: 19091453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable cardioverter defibrillator.
    Silva RM; Mont L; Nava S; Rojel U; Matas M; Brugada J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):971-5. PubMed ID: 15271018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fascicular ventricular tachycardia: experience with radiofrequency ablation.
    Magalhaes S; Gonçalves H; Primo J; Sá AP; Silva P; Rosas R; Gama V
    Rev Port Cardiol; 2006 May; 25(5):485-97. PubMed ID: 16910156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the ventricular tachycardia isthmus after infarction by pace mapping.
    Brunckhorst CB; Delacretaz E; Soejima K; Maisel WH; Friedman PL; Stevenson WG
    Circulation; 2004 Aug; 110(6):652-9. PubMed ID: 15289385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid therapies for ventricular arrhythmias.
    Bella PD; Riva S
    Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S40-7. PubMed ID: 17169132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation of subepicardial ventricular tachycardia using electroanatomic mapping.
    Ouyang F; Bänsch D; Schaumann A; Ernst S; Linder C; Falk P; Hachiya H; Kuck KH; Antz M
    Herz; 2003 Nov; 28(7):591-7. PubMed ID: 14689119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
    Glikson M; Lipchenca I; Viskin S; Ballman KV; Trusty JM; Gurevitz OT; Luria DM; Eldar M; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):658-64. PubMed ID: 15175060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].
    Tanner H; Hindricks G; Kottkamp H
    Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency catheter ablation as primary therapy for symptomatic ventricular tachycardia.
    Jadonath RL; Snow JS; Goldner BG; Cohen TJ
    J Invasive Cardiol; 1994; 6(9):289-95. PubMed ID: 10155085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of ventricular tachycardia in patients with structural heart disease.
    Jacobson JT; Weiner JB
    Cardiovasc Ther; 2010 Oct; 28(5):255-63. PubMed ID: 20433682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.